Divi's Laboratories Limited (DIVISLAB.NS)
INR 5640.0
(-1.98%)
INR 5640.0
(-1.98%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 18.31 Billion INR | -22.89% |
| 2022 | 23.69 Billion INR | -35.72% |
| 2021 | 36.85 Billion INR | 38.06% |
| 2020 | 26.69 Billion INR | 50.88% |
| 2019 | 17.69 Billion INR | -3.37% |
| 2018 | 18.31 Billion INR | 48.22% |
| 2017 | 12.35 Billion INR | -11.43% |
| 2016 | 13.94 Billion INR | 0.82% |
| 2015 | 13.83 Billion INR | 28.13% |
| 2014 | 10.79 Billion INR | 8.26% |
| 2013 | 9.97 Billion INR | 27.43% |
| 2012 | 7.82 Billion INR | 17.25% |
| 2011 | 6.67 Billion INR | 40.68% |
| 2010 | 4.74 Billion INR | 22.28% |
| 2009 | 3.88 Billion INR | -96.49% |
| 2008 | 110.71 Billion INR | 2832.79% |
| 2007 | 3.77 Billion INR | 72.19% |
| 2006 | 2.19 Billion INR | 107.45% |
| 2005 | 1.05 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | 4.7 Billion INR | -4.47% |
| 2023 FY | 18.27 Billion INR | -22.89% |
| 2023 Q4 | 5.26 Billion INR | -17.3% |
| 2023 Q3 | 6.36 Billion INR | 30.06% |
| 2023 Q2 | 4.89 Billion INR | 4.04% |
| 2022 Q3 | 4.66 Billion INR | 7.1% |
| 2022 Q1 | 6.15 Billion INR | -27.72% |
| 2022 FY | 23.69 Billion INR | -35.72% |
| 2022 Q2 | 4.35 Billion INR | -29.19% |
| 2022 Q4 | 4.92 Billion INR | 5.42% |
| 2021 Q2 | 10.33 Billion INR | 36.07% |
| 2021 Q4 | 8.51 Billion INR | -20.98% |
| 2021 Q3 | 10.77 Billion INR | 4.21% |
| 2021 Q1 | 7.59 Billion INR | -6.74% |
| 2021 FY | 36.85 Billion INR | 38.06% |
| 2020 Q3 | 6.69 Billion INR | 4.18% |
| 2020 FY | 26.69 Billion INR | 50.88% |
| 2020 Q4 | 8.14 Billion INR | 21.75% |
| 2020 Q2 | 6.42 Billion INR | -7.4% |
| 2020 Q1 | 6.93 Billion INR | 4.91% |
| 2019 Q1 | 4.91 Billion INR | 31.59% |
| 2019 Q3 | 4.15 Billion INR | -15.06% |
| 2019 Q4 | 6.61 Billion INR | 59.22% |
| 2019 FY | 17.69 Billion INR | -3.37% |
| 2019 Q2 | 4.88 Billion INR | -0.57% |
| 2018 Q2 | 5.24 Billion INR | -6.2% |
| 2018 FY | 18.31 Billion INR | 48.22% |
| 2018 Q4 | 3.73 Billion INR | -3.58% |
| 2018 Q3 | 3.87 Billion INR | -26.16% |
| 2018 Q1 | 5.59 Billion INR | 55.68% |
| 2017 FY | 12.35 Billion INR | -11.43% |
| 2017 Q4 | 3.59 Billion INR | 0.0% |
| 2016 FY | 13.94 Billion INR | 0.82% |
| 2015 FY | 13.83 Billion INR | 28.13% |
| 2014 Q3 | 2.93 Billion INR | 0.0% |
| 2014 FY | 10.79 Billion INR | 8.26% |
| 2013 FY | 9.97 Billion INR | 27.43% |
| 2013 Q3 | 2.54 Billion INR | 0.0% |
| 2012 Q3 | 2.37 Billion INR | 0.0% |
| 2012 FY | 7.82 Billion INR | 17.25% |
| 2011 FY | 6.67 Billion INR | 40.68% |
| 2010 FY | 4.74 Billion INR | 22.28% |
| 2009 FY | 3.88 Billion INR | -96.49% |
| 2008 FY | 110.71 Billion INR | 2832.79% |
| 2007 FY | 3.77 Billion INR | 72.19% |
| 2006 FY | 2.19 Billion INR | 107.45% |
| 2005 FY | 1.05 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hester Biosciences Limited | 364.77 Million INR | -4919.601% |
| Albert David Limited | 1.33 Billion INR | -1272.094% |
| Alembic Limited | 767.77 Million INR | -2284.829% |
| Alkem Laboratories Limited | 19.46 Billion INR | 5.919% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -217.987% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -7604.251% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| FDC Limited | 3.03 Billion INR | -503.545% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -103.916% |
| Gufic Biosciences Limited | 2.89 Billion INR | -532.731% |
| Hikal Limited | 1.49 Billion INR | -1125.405% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -811.384% |
| Ind-Swift Limited | 1.22 Billion INR | -1393.519% |
| Innova Captab Limited | 2.53 Billion INR | -622.741% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -8454.476% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -252.862% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -8700.769% |
| Laurus Labs Limited | 3.94 Billion INR | -363.709% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -860.485% |
| Lupin Limited | 27.75 Billion INR | 34.037% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -66583.662% |
| Medico Remedies Limited | 277.11 Million INR | -6507.294% |
| Morepen Laboratories Limited | 4.17 Billion INR | -338.686% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -370.623% |
| Orchid Pharma Limited | 2.36 Billion INR | -675.493% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -557.215% |
| RPG Life Sciences Limited | 2.29 Billion INR | -698.761% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 575.226% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 82.446% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -297.383% |
| Themis Medicare Limited | 1.3 Billion INR | -1305.105% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -290811.98% |
| Venus Remedies Limited | 534.65 Million INR | -3324.664% |
| Wanbury Limited | 1.7 Billion INR | -972.512% |
| Windlas Biotech Limited | 1.29 Billion INR | -1309.665% |
| ZIM Laboratories Limited | 1.09 Billion INR | -1567.406% |
| Ipca Laboratories Limited | 29.59 Billion INR | 38.135% |
| Aarti Drugs Limited | 7.14 Billion INR | -156.13% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -485.336% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -88542.525% |
| Brooks Laboratories Limited | -72.25 Million INR | 25441.859% |
| Eris Lifesciences Limited | 5.18 Billion INR | -253.358% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -270.483% |
| Sigachi Industries Limited | 1.47 Billion INR | -1142.286% |
| Sakar Healthcare Limited | 495.5 Million INR | -3595.213% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 82.479% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -309.263% |
| Mankind Pharma Limited | 40.86 Billion INR | 55.197% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 5.31 Billion INR | -244.296% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -142.785% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -181.589% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 59.662% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -2848.342% |
| Wockhardt Limited | 140 Million INR | -12978.571% |
| Bal Pharma Limited | 214.56 Million INR | -8433.386% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 72.966% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -1387.407% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -3219.501% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -153.415% |
| Shilpa Medicare Limited | 3.76 Billion INR | -386.765% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 6.949% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -646707.681% |
| Granules India Limited | 6.52 Billion INR | -180.473% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -7246.009% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 27.729% |
| NATCO Pharma Limited | 25.96 Billion INR | 29.474% |
| Suven Life Sciences Limited | -1.22 Billion INR | 1593.692% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -250.376% |
| Indoco Remedies Limited | 1.52 Billion INR | -1101.128% |
| Alpa Laboratories Limited | 61.51 Million INR | -29665.098% |
| Lasa Supergenerics Limited | -458 Million INR | 4097.773% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 544.953% |